Reetta Riikonen

548 total citations
19 papers, 433 citations indexed

About

Reetta Riikonen is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Genetics. According to data from OpenAlex, Reetta Riikonen has authored 19 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 9 papers in Molecular Biology and 8 papers in Genetics. Recurrent topics in Reetta Riikonen's work include Prostate Cancer Treatment and Research (11 papers), Estrogen and related hormone effects (6 papers) and Protein Degradation and Inhibitors (6 papers). Reetta Riikonen is often cited by papers focused on Prostate Cancer Treatment and Research (11 papers), Estrogen and related hormone effects (6 papers) and Protein Degradation and Inhibitors (6 papers). Reetta Riikonen collaborates with scholars based in Finland, France and Austria. Reetta Riikonen's co-authors include Riikka Oksala, Gerd Wohlfahrt, Pekka Kallio, Anu‐Maarit Moilanen, Olli Törmäkangas, Laura Ravanti, Jorma J. Palvimo, Pirjo Nykänen, Jyrki Heino and Olli T. Pentikäinen and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Reetta Riikonen

18 papers receiving 427 citations

Peers

Reetta Riikonen
Lara K. Boyd United Kingdom
K. N. Canada
Andrei Y. Volgin United States
Gaoda Ju China
Paul Hartman United States
A. Seun Ajiboye United States
Li‐Yan Khor United States
K. Papadopoulos United States
Ben Staal United States
D. Solit United States
Lara K. Boyd United Kingdom
Reetta Riikonen
Citations per year, relative to Reetta Riikonen Reetta Riikonen (= 1×) peers Lara K. Boyd

Countries citing papers authored by Reetta Riikonen

Since Specialization
Citations

This map shows the geographic impact of Reetta Riikonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reetta Riikonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reetta Riikonen more than expected).

Fields of papers citing papers by Reetta Riikonen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reetta Riikonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reetta Riikonen. The network helps show where Reetta Riikonen may publish in the future.

Co-authorship network of co-authors of Reetta Riikonen

This figure shows the co-authorship network connecting the top 25 collaborators of Reetta Riikonen. A scholar is included among the top collaborators of Reetta Riikonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reetta Riikonen. Reetta Riikonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Riikonen, Reetta, Päivi Taavitsainen, Marcin Chruściel, et al.. (2022). First-in-Class Small Molecule to Inhibit CYP11A1 and Steroid Hormone Biosynthesis. Molecular Cancer Therapeutics. 21(12). 1765–1776. 15 indexed citations
2.
3.
Oksala, Riikka, Reetta Riikonen, Kati Räsänen, et al.. (2019). SUN-LB002 CYP11A1 Inhibition as a Therapeutic Approach for the Treatment of Castration Resistant Prostate Cancer. Journal of the Endocrine Society. 3(Supplement_1). 3 indexed citations
4.
Björkman, Mari, Reetta Riikonen, Daniel Nicorici, et al.. (2019). Abstract 3827: Antitumor activity of ODM-207, a novel BET bromodomain inhibitor, in nonclinical models of ER+ breast cancer as single agent and as a combination treatment. Cancer Research. 79(13_Supplement). 3827–3827. 3 indexed citations
5.
6.
Oksala, Riikka, Reetta Riikonen, Petteri Rummakko, et al.. (2018). Discovery and development of ODM-204: A Novel nonsteroidal compound for the treatment of castration-resistant prostate cancer by blocking the androgen receptor and inhibiting CYP17A1. The Journal of Steroid Biochemistry and Molecular Biology. 192. 105115–105115. 16 indexed citations
7.
Oksala, Riikka, Reetta Riikonen, Petteri Rummakko, et al.. (2018). CYP11A1 inhibition as a therapeutic approach for the treatment of castration resistant prostate cancer.. Journal of Clinical Oncology. 36(6_suppl). 340–340. 4 indexed citations
8.
Björkman, Mari, Reetta Riikonen, Daniel Nicorici, et al.. (2018). Abstract 3970: Therapeutic targeting of estrogen receptor positive breast cancer with the BET bromodomain inhibitor ODM-207. Cancer Research. 78(13_Supplement). 3970–3970. 1 indexed citations
9.
Oksala, Riikka, Kati Räsänen, Reetta Riikonen, et al.. (2018). CYP11A1 inhibition as a therapeutic approach for the treatment of castration resistant prostate cancer. Annals of Oncology. 29. viii292–viii292. 1 indexed citations
10.
Oksala, Riikka, Reetta Riikonen, Petteri Rummakko, et al.. (2017). ODM-208, a novel CYP11A1-inhibitor as a therapeutic approach for the treatment of castration-resistant prostate cancer. Annals of Oncology. 28. v8–v8. 2 indexed citations
11.
Moilanen, Anu‐Maarit, Mari Björkman, Reetta Riikonen, et al.. (2017). Abstract 118: Targeting cancer with a novel BET bromodomain inhibitor ODM-207. Cancer Research. 77(13_Supplement). 118–118. 1 indexed citations
12.
Björkman, Mari, Elina Mattila, Reetta Riikonen, et al.. (2016). Abstract 4649: ODM-207, a novel BET-bromodomain inhibitor as a therapeutic approach for the treatment of prostate and breast cancer. Cancer Research. 76(14_Supplement). 4649–4649. 3 indexed citations
13.
Kallio, Pekka, et al.. (2016). ODM-204, a novel dual inhibitor of CYP17A1 and androgen receptor for the treatment of castration-resistant prostate cancer.. Journal of Clinical Oncology. 34(2_suppl). 230–230.
14.
Björkman, Mari, Elina Mattila, Reetta Riikonen, et al.. (2016). ODM-207, a novel BET-bromodomain inhibitor as a therapeutic approach for the treatment of patients with castration resistant prostate cancer. European Journal of Cancer. 69. S89–S90. 1 indexed citations
15.
Moilanen, Anu‐Maarit, Reetta Riikonen, Riikka Oksala, et al.. (2015). Discovery of ODM-201, a new-generation androgen receptor inhibitor targeting resistance mechanisms to androgen signaling-directed prostate cancer therapies. Scientific Reports. 5(1). 12007–12007. 282 indexed citations
16.
Oksala, Riikka, et al.. (2015). ODM-204: A novel dual inhibitor of CYP17A1 and androgen receptor for the treatment of castration-resistant prostate cancer—Preclinical data.. Journal of Clinical Oncology. 33(7_suppl). 221–221. 1 indexed citations
17.
Matilainen, Heli, Anna R. Mäkelä, Reetta Riikonen, et al.. (2006). RGD motifs on the surface of baculovirus enhance transduction of human lung carcinoma cells. Journal of Biotechnology. 125(1). 114–126. 20 indexed citations
18.
Riikonen, Reetta, Heli Matilainen, Nina Rajala, et al.. (2005). Functional Display of an α2 Integrin-Specific Motif (RKK) on the Surface of Baculovirus Particles. Technology in Cancer Research & Treatment. 4(4). 437–445. 10 indexed citations
19.
Käpylä, Jarmo, Johanna Ivaska, Reetta Riikonen, et al.. (2000). Integrin α2I Domain Recognizes Type I and Type IV Collagens by Different Mechanisms. Journal of Biological Chemistry. 275(5). 3348–3354. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lara K. Boyd Breakdown of academic impact, for papers by K. N. Breakdown of academic impact, for papers by Andrei Y. Volgin Breakdown of academic impact, for papers by Gaoda Ju Breakdown of academic impact, for papers by Paul Hartman Breakdown of academic impact, for papers by A. Seun Ajiboye Breakdown of academic impact, for papers by Li‐Yan Khor Breakdown of academic impact, for papers by K. Papadopoulos Breakdown of academic impact, for papers by Ben Staal Breakdown of academic impact, for papers by D. Solit
Rankless by CCL
2026